# FDA recall D-764-2014

> **Cubist Pharmaceuticals, Inc.** · Class I · drug recall initiated 2013-08-29.

## Product

Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA

## Reason for recall

Presence of Particulate Matter; Glass particulates observed in vials

## Distribution

Nationwide

## Key facts

- **Recall number:** D-764-2014
- **Recalling firm:** Cubist Pharmaceuticals, Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-08-29
- **Report date:** 2014-01-29
- **Termination date:** 2015-02-10

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lexington, MA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-764-2014

## Citation

> AI Analytics. FDA recall D-764-2014. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-764-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*